A Phase 1 study of a recombinant viruslike particle vaccine against human papillomavirus type 11 in healthy adult volunteers

The Journal of Infectious Diseases
T G EvansR C Reichman

Abstract

Viruslike particles (VLPs) produced from the L1 protein of several papillomaviruses have induced protection from infection after live challenge in animal models. In the present study, the safety and immunogenicity of a human papillomavirus (HPV)--11 L1 VLP candidate vaccine were measured in a phase 1, dose-finding trial in humans. The vaccine was well tolerated and induced high levels of both binding and neutralizing antibodies. Marked increases in lymphoproliferation to HPV--11 L1 antigens were noted after the second vaccination. In addition, lymphoproliferation was induced after vaccination in peripheral blood mononuclear cells (PBMC) stimulated with heterologous L1 VLP antigens of HPV types 6 and 16. Statistically significant increases in HPV antigen--specific interferon--gamma and interleukin-5 production were measured from PBMC culture supernatants. This candidate HPV VLP vaccine induced robust B and T cell responses, and T cell helper epitopes appear to be conserved across HPV types.

Citations

May 15, 2007·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·M Müller, L Gissmann
Feb 28, 2002·Journal of Immunological Methods·Jaafar BennounaTheresa L Whiteside
Feb 5, 2003·Journal of Virological Methods·Xin-Min WangWilliam L McClements
Sep 19, 2003·Trends in Microbiology·Rob Noad, Polly Roy
Jan 28, 2003·Drug Discovery Today·Joanne Clough
Aug 7, 2003·The Lancet Infectious Diseases·Denise A Galloway
May 8, 2009·Immunology and Cell Biology·Balasubramanyam KaranamRichard B S Roden
Sep 23, 2006·Nature Reviews. Cancer·Richard Roden, T-C Wu
Mar 20, 2004·Nature Reviews. Microbiology·John T Schiller, Philip Davies
Aug 20, 2010·Sexual Health·Ian H Frazer
Nov 12, 2005·The Pediatric Infectious Disease Journal·William Bonnez
Sep 14, 2004·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·W A A TjalmaJ J Bogers
Mar 17, 2007·Acta Ophthalmologica Scandinavica·Nicolai Christian SjöGerard Orth
Apr 27, 2007·Journal of Virology·Jiafen HuNeil D Christensen
Jul 30, 2003·Journal of Virology·Heribert WarzechaRobert C Rose
Jan 30, 2004·Annual Review of Medicine·Kathrin U Jansen, Alan R Shaw
Mar 1, 2008·Biologics : Targets & Therapy·Archana MonieT-C Wu
May 29, 2008·Future Microbiology·Aileen Murphy, Polly Roy
Oct 3, 2006·Expert Review of Anti-infective Therapy·James E KendrickRonald D Alvarez
Oct 7, 2009·Expert Review of Vaccines·Franco Maria BuonaguroLuigi Buonaguro
Nov 3, 2011·Expert Review of Vaccines·Luigi BuonaguroFranco M Buonaguro
Mar 11, 2005·Expert Review of Anticancer Therapy·James MacleanAnna-Lise Williamson
Aug 3, 2007·Expert Review of Vaccines·Alejandro García Carrancá, Silvia C Galván
Dec 1, 2001·Expert Opinion on Biological Therapy·J T Schiller, D R Lowy
Oct 20, 2006·Expert Opinion on Biological Therapy·Engy Hanna, Gloria Bachmann
Aug 27, 2005·Expert Opinion on Biological Therapy·George CoukosT-C Wu
Oct 27, 2004·Expert Opinion on Biological Therapy·Kathrin U Jansen
Jul 23, 2004·Expert Opinion on Biological Therapy·Jeffrey B Ulmer
Jun 5, 2003·Expert Opinion on Biological Therapy·Gunther Spohn, Martin F Bachmann
Dec 10, 2002·International Journal of Cancer. Journal International Du Cancer·Hai-Rim ShinSilvia Franceschi
Oct 27, 2009·Archives of Medical Research·Vicente Madrid-MarinaAlejandro García-Carrancá
Sep 22, 2009·La Presse médicale·Christiane MouginPierre Coursaget
May 18, 2006·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Michelle Giles, Suzanne Garland

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.